Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
888
NCT02366026
REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 30, 2017
Completion: Jun 30, 2019
NCT02291809
REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Phase: Phase 2
Start: Nov 30, 2017
Completion: Nov 30, 2019
NCT02057159
A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Phase: Phase 2/3
Start: Mar 9, 2020
Completion: Mar 9, 2023
NCT02149706
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Completion: Mar 9, 2022
NCT02200718
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis
Phase: Phase 1
Start: Dec 31, 2020
Completion: Nov 9, 2024